Translator Disclaimer
1 September 2009 Effect of Dosage and Vaccination Route on Transmission of a Live Attenuated Mycoplasma gallisepticum Vaccine: A Broiler Model
Author Affiliations +
Abstract

Mycoplasma gallisepticum (MG) is an economically significant pathogen of poultry species. Among the table egg sector of the poultry industry, live attenuated strains of MG are commonly used to limit production losses associated with MG-induced disease. These vaccines, however, may be problematic to broiler- and turkey-related industries because of associated virulence; therefore, an understanding of the transmissibility of the live MG vaccines is of particular importance. In the present study, a broiler model addresses the effect of vaccine application route and dosage on the transmission of the MG vaccine FVAX-MG® to commingled unvaccinated subjects for 7 wk postvaccination. Vaccinations occurred at 2 wk of age via eyedrop or spray application at 1× (4 × 106 colony-forming units [cfu]), 10−3× (4 × 103 cfu), or 10−6× (4 cfu) of the manufacturer's recommended dosage, and subsequent transmission to unvaccinated subjects was measured. The serologic response to MG antigen and the presence of MG DNA indicated FVAX-MG transmission only within the 1× FVAX-MG eyedrop treatment. Among no other treatment was transmission of FVAX-MG detected. The results of the present study demonstrate that the dosage and vaccination route may have direct implications on subsequent transmission of FVAX-MG.

J. D. Evans, S. L. Branton, and S. A. Leigh "Effect of Dosage and Vaccination Route on Transmission of a Live Attenuated Mycoplasma gallisepticum Vaccine: A Broiler Model," Avian Diseases 53(3), 416-420, (1 September 2009). https://doi.org/10.1637/8621-012309-Reg.1
Received: 29 January 2009; Accepted: 1 April 2009; Published: 1 September 2009
JOURNAL ARTICLE
5 PAGES


SHARE
ARTICLE IMPACT
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top